Pest management professionals battling the ongoing resurgence of bed bugs are wise to employ a well-rounded set of measures that reduces reliance on chemical control, as new research shows the early signs of resistance developing among bed bugs to two commonly used insecticides. In a study to be published next week in the Entomological Society of America's Journal of Economic Entomology, researchers at Purdue University found significantly reduced susceptibility to chlorfenapyr among three out of 10 bed bug populations collected in the field, and they found reduced susceptibility to bifenthrin among five of the populations.
The common bed bug (Cimex lectularius) already shows significant resistance to deltamethrin and some other pyrethroid-class insecticides, which is viewed as a main cause of its resurgence as an urban pest. In fact, 68 percent of pest management professionals identify bed bugs as the most difficult pest to control, according to a 2015 Bugs Without Borders survey of pest management professionals conducted by the National Pest Management Association and the University of Kentucky. Little research had yet been done, however, to examine potential resistance to bifenthrin (also a pyrethroid) or chlorfenapyr, a pyrrole-class insecticide, which led the Purdue researchers to investigate.
"In the past, bed bugs have repeatedly shown the ability to develop resistance to products overly relied upon for their control. The findings of the current study also show similar trends in regard to chlorfenapyr and bifenthrin resistance development in bed bugs," says Ameya D. Gondhalekar, PhD, research assistant professor at Purdue's Center for Urban and Industrial Pest Management. "With these findings in mind and from an insecticide resistance management perspective, both bifenthrin and chlorfenapyr should be integrated with other methods used for bed bug elimination in order to preserve their efficacy in the long term."
They tested 10 populations of bed bugs that were collected and contributed by pest management professionals and university researchers in Indiana, New Jersey, Ohio, Tennessee, Virginia, and Washington, D.C., measuring the percent of bed bugs killed within seven days of exposure to the insecticides. Generally, populations in which more than 25 percent of the beg bugs survived were deemed to have reduced susceptibility to the insecticide based on statistical analysis performed in comparison to the susceptible laboratory population.
Interestingly, the researchers found a correlation between chlorfenapyr and bifenthrin susceptibility among the bed bug populations, which was unexpected because the two insecticides work in different ways. Gondhalekar says further research is needed to understand why the bed bugs that are less susceptible can withstand exposure to these insecticides, especially chlorfenapyr. In any case, adherence to integrated pest management practices will slow the further development of resistance.
"There is a plethora of research that has shown that if insecticides are integrated with additional control measures such as vacuuming, steam or heat, mattress encasements, traps, and desiccant dusts, effective bed bug control can be accomplished and theoretically this should reduce the risk of resistance build-up in populations," Gondhalekar says.
"Detection of Reduced Susceptibility to Chlorfenapyr- and Bifenthrin-Containing Products in Field Populations of the Bed Bug (Hemiptera: Cimicidae)," by Aaron R. Ashbrook, Michael E. Scharf, Gary W. Bennett, and Ameya D. Gondhalekar, will be published online on April 10 in the Journal of Economic Entomology.
Source: Entomological Society of America
An Infection Preventionist Considers Why Manufacturers Need to Update IFUs
July 11th 2024Katharine J. Hoffman, MPH, CIC, LSSGB: It’s time to take the devil out of the details in interpreting and successfully following manufacturers' instructions for use; why do manufacturers need to update IFUs?
Streamlining Hospital Communication: Reducing Noise and Improving Patient Care
June 27th 2024TigerConnect's secure text-based platform, led by Will O'Connor, MD, reduces noise, minimizes wait times, and improves patient care through efficient clinical workflow coordination and nurse burnout alleviation.
Overcoming Limitations in a Low-Resource Facility: Spotlight on the Navajo Nation
June 10th 2024Sage Memorial Hospital, Navajo Health Foundation in Arizona tackles health care and infection control challenges through innovative strategies and cultural sensitivity, serving the Navajo community with respect and resilience.